Primmune Therapeutics
Randy Adams is currently the Senior VP of Strategic Marketing and Communications at Endeavor Biomedicines. Randy has held various senior roles in marketing and commercial strategy at companies such as Primmune Therapeutics, Equillium Inc., Impact Biomedicines, Carling Communications, Zimmer Dental, Allergan Pharmaceuticals, and Women First Healthcare. With a strong background in healthcare marketing and sales operations, Randy brings a wealth of experience to the industry.
Primmune Therapeutics
1 followers
Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Their goal is to improve the response rate of patients to current and future immunotherapy medicines.